FTC Seeks Input On How PBM Rebating Practices Affect Drug ‘Affordability,’ Access

With formal study still stalled, the information collection will enable FTC to examine a ‘wide array’ of pharmacy benefit manager business practices impacting patients, payers and pharmacies.